title: The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.
abstract: Rectal neuroendocrine tumors (NETs) can be classified by histologic pattern and secretory products. Recently, rectal NETs have been noted to exhibit immunohistochemical (IHC) positivity for Islet 1 and PAX8, which are generally considered markers for NETs of pancreatic origin. In this study, we sought to characterize the IHC staining profile of rectal NETs and determine whether there was any correlation between the histologic pattern of rectal NETs and their IHC profile. Fifty-six primary rectal NETs were histologically reviewed and stained with antibodies against Islet 1, PAX8, CDX2, chromogranin A, and synaptophysin. In a subset of 31 cases, immunoreactivity for serotonin, pancreatic polypeptide (PP), and prostatic acid phosphatase (PAP) was also studied. By morphology, the tumors studied included 55 % trabecular, 27 % solid nested, 4 % acinar, and 14 % mixed patterns. Islet 1 was positive in 89 % and PAX8 in 79 % of cases. CDX2 was negative in all 56 cases. Cytoplasmic staining was observed for chromogranin A in 30 % of cases and for synaptophysin in all 56 cases. Cytoplasmic staining for serotonin, PP, and PAP was present in 16, 61, and 97 % of cases, respectively. There was no correlation between histologic pattern and IHC staining pattern with any of the antibodies studied. We have demonstrated that Islet 1 and PAX8 are not entirely specific for NETs of pancreatic origin, as they are expressed in a majority of rectal NETs. Since rectal NETs may show an IHC staining profile which mirrors that of pancreatic NETs (Islet 1 and PAX8-positive, CDX2-negative), a metastatic rectal NET should be considered in the differential diagnosis and ruled out clinically in the work-up of a metastatic NET of unknown primary origin which exhibits this staining profile.
authors.affiliation: Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA, jakoo@mednet.ucla.edu.
authors.forename: Jamie
authors.initials: J
authors.lastname: Koo
authors.forename: Xiaoyan
authors.initials: X
authors.lastname: Zhou
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Moschiano
authors.forename: Mariza
authors.initials: M
authors.lastname: De Peralta-Venturina
authors.forename: Richard B
authors.initials: RB
authors.lastname: Mertens
authors.forename: Deepti
authors.initials: D
authors.lastname: Dhall
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000071616:CDX2 Transcription Factor; D053379:Chromogranin A / Q000378:metabolism; D003937:Diagnosis, Differential; D005260:Female; D018398:Homeodomain Proteins / Q000378:metabolism; D006801:Humans; D060850:LIM-Homeodomain Proteins / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009382:Neoplasms, Unknown Primary / Q000175:diagnosis* / Q000378:metabolism / Q000473:pathology; D018358:Neuroendocrine Tumors / Q000175:diagnosis* / Q000378:metabolism / Q000556:secondary; D000072636:PAX8 Transcription Factor; D051761:Paired Box Transcription Factors / Q000378:metabolism*; D012004:Rectal Neoplasms / Q000175:diagnosis* / Q000378:metabolism / Q000556:secondary; D016708:Synaptophysin / Q000378:metabolism; D014157:Transcription Factors / Q000378:metabolism*
chemical_list: D000071616:CDX2 Transcription Factor; C491270:CDX2 protein, human; D053379:Chromogranin A; D018398:Homeodomain Proteins; D060850:LIM-Homeodomain Proteins; D000072636:PAX8 Transcription Factor; C083325:PAX8 protein, human; D051761:Paired Box Transcription Factors; D016708:Synaptophysin; D014157:Transcription Factors; C063843:insulin gene enhancer binding protein Isl-1
references.citation: Cancer. 1971 Oct;28(4):990-8
references.pmid: 4106849
references.citation: Pancreas. 2011 Aug;40(6):883-95
references.pmid: 21705949
references.citation: Biochem Pharmacol. 2007 Jan 1;73(1):1-14
references.pmid: 16904651
references.citation: Cancer. 1990 Mar 1;65(5):1219-27
references.pmid: 1689211
references.citation: Histochem J. 1981 Nov;13(6):961-73
references.pmid: 6175605
references.citation: Am J Surg Pathol. 2008 Mar;32(3):420-5
references.pmid: 18300808
references.citation: Trends Genet. 2000 Feb;16(2):75-83
references.pmid: 10652534
references.citation: Am J Surg Pathol. 2004 Sep;28(9):1169-76
references.pmid: 15316316
references.citation: Hum Pathol. 2012 Aug;43(8):1169-76
references.pmid: 22221702
references.citation: Am J Surg Pathol. 2009 Apr;33(4):626-32
references.pmid: 19065104
references.citation: Regul Pept. 1987 Jan;17(1):9-29
references.pmid: 2882565
references.citation: Am J Surg Pathol. 2010 May;34(5):723-9
references.pmid: 20414099
references.citation: Mod Pathol. 2011 Mar;24(3):412-24
references.pmid: 20890270
references.citation: Cancer. 1990 Jan 1;65(1):135-40
references.pmid: 2293859
references.citation: Am J Pathol. 2000 Oct;157(4):1299-309
references.pmid: 11021834
references.citation: Arch Pathol Lab Med. 1983 May;107(5):277
references.pmid: 6301401
references.citation: Ann Pathol. 1996;16(2):98-103
references.pmid: 8767675
references.citation: Endocr Pathol. 2004 Fall;15(3):247-52
references.pmid: 15640551
references.citation: Am J Clin Pathol. 2005 Mar;123(3):394-404
references.pmid: 15716236
references.citation: Arch Pathol Lab Med. 2006 Oct;130(10):1522-6
references.pmid: 17090195
references.citation: Appl Immunohistochem Mol Morphol. 2007 Dec;15(4):407-14
references.pmid: 18091383
references.citation: Virchows Arch. 2004 Sep;445(3):248-54
references.pmid: 15517368
references.citation: Virchows Arch A Pathol Anat Histopathol. 1986;410(3):247-51
references.pmid: 3026083
references.citation: Virchows Arch. 1995;426(4):361-7
references.pmid: 7599788
references.citation: Mod Pathol. 2012 Jun;25(6):893-901
references.pmid: 22388755
references.citation: Am J Surg Pathol. 1991 Aug;15(8):785-90
references.pmid: 1712549
references.citation: Cancer. 1986 Jul 1;58(1):136-8
references.pmid: 2423222
references.citation: Mod Pathol. 2013 Jul;26(7):995-1003
references.pmid: 23503646
references.citation: Virchows Arch. 1994;425(2):127-32
references.pmid: 7952497
references.citation: Mod Pathol. 2000 Feb;13(2):140-6
references.pmid: 10697270